The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

Neuroscience Letters

Volumn 270, Issue 1, 1999, Pages 1-4

  Harhangi, B Sanjay ^a   Farrer, Matthew J ^b   Lincoln, Sarah ^b   Bonifati, Vincenzo ^c   Meco, Giuseppe ^c   De Michele, Giuseppe ^d   Brice, Alexis ^e   Dürr, Alexandra ^e   Martinez, Maria ^e   Gasser, Thomas ^f   Bereznai, Benjamin ^f   Vaughan, Jenny R ^g   Wood, Nicholas W ^g   Hardy, John ^b   Oostra, Ben A ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e INSERM   (France)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Candidate gene; Family studies; Genetics; Parkinson's disease; Ubiquitin carboxy terminal hydrolase L1

Indexed keywords

HYDROLASE; ISOLEUCINE; METHIONINE; UBIQUITIN;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; EUROPE; FAMILIAL DISEASE; GENE MUTATION; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RACE; SIBLING;

EID: 0033597972     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00465-6     Document Type: Article

References (20)

1. Abbas N., Lücking C.B., Ricard S., Dürr A., Bonifati V., De Michele G., Bouley S., Vaughan J.R., Gasser T., Marconi R., Broussolle E., Brefel-Courbon C., Harhangi B.S., Oostra B.A., Fabrizio E., Böhme G.A., Pradier L., Wood N.W., Filla A., Meco G., Denefle P., Agid Y., Brice A. The French Parkinson's Disease Genetics Study Group and The European Consortium on Genetic Susceptibility in Parkinson's Disease. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Hum. Mol. Genet. 8:1999;567-574.
2. de Rijk M.C., Breteler M.M.B., Graveland G.A., Ott A., Grobbee D.E., van der Meche F.G.A., Hofman A. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 45:1995;2143-2146.
3. de Rijk M.C., Tzourio C., Breteler M.M.B., Dartigues J.F., Amaducci L., Lopez-Pousa S., Manubens-Bertran J.M., Alperovitch A., Rocca W.A. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 62:1997;10-15.
4. Dickson D.W., Farrer M.J., Mehta N.D., Perez-Tur J., Tiseo P., Yen S-H., Hardy J. Antibodies to non-amyloid component of plaques (NACP) specifically label Lewy bodies and Lewy neurites, but not other inclusions in neurodegenerative diseases. J. Neuropath. Exp. Neurol. 57:1998;516.
5. Edwards Y.H., Fox M.F., Povey S., Hinks L.J., Thompson R.J., Day I.N. The gene for human neurone specific ubiquitin C-terminal hydrolase (UCHL1, PGP9.5) maps to chromosome 4p14. Ann. Hum. Genet. 55:1991;273-278.
6. Farrer M.J., Gwinn-Hardy K., Muenter M., Wavrant DeVrieze F., Crook R., Perez-Tur J., Lincoln S., Maraganore D., Adler C., Newman S., MacElwee K., McCarthy P., Miller C., Waters C., Hardy J. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum. Mol. Genet. 8:1999;81-85.
7. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 55:1992;181-184.
8. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
9. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
10. Larsen C.N., Krantz B.A., Wilkinson K.D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry. 37:1998;3358-3368.
11. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
12. Lincoln S., Vaughan J.R., Wood N.W., Baker M., Adamson J., Gwinn-Hardy K., Lynch T., Hardy J., Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy terminal hydrolase gene in familial Parkinson's disease. NeuroReport. 10:(2):1999;427-429.
13. Lowe J., McDermott H., Landon M., Mayer R.J., Wilkinson K.D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161:1990;153-160.
14. Manetto V., Abdul-Karim F.W., Perry G., Tabaton M., Autilio-Gambetti L., Gambetti P. Selective presence of ubiquitin in intracellular inclusions. Am. J. Pathol. 134:1989;505-513.
15. Maraganore D.M., Harding A.E., Marsden C.D. A clinical and genetic study of familial Parkinson's disease. Mov. Disord. 6:1991;205-211.
16. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science. 235:1987;1641-1644.
17. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
18. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840.
19. Tassin J., Dürr A., de Broucker T., Abbas N., Bonifati V., De Michele G., Bonnet A.M., Broussolle E., Pollak P., Vidailhet M., De Mari M., Marconi R., Medjbeur S., Filla A., Meco G., Agid Y., Brice A. Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Am. J. Hum. Genet. 63:1998;88-94.
20. Vaughan J.R., Durr A., Tassin J., Bereznai B., Gasser T., Bonifati V., De Michele G., Fabrizio E., Volpe G., Bandmann O., Johnson W.G., Golbe L.I., Breteler M., Meco G., Agid Y., Brice A., Marsden C.D., Wood N.W. The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease. Ann. Neurol. 44:1998;270-273.